Valiant Laboratories Limited
Incorporated in 1980, Valiant Laboratories Limited is a pharmaceutical ingredient manufacturing company in India having focuses on manufacturing Paracetamol.
What Valiant files
- Others61
- Board Meeting17
- Important12
- Results5
- Updates4
- Credit Ratings3
Valiant Labs will hold its 5th Annual General Meeting via VC/OAVM. Shareholders can access the Annual Report for FY2025-26 and AGM Notice through the company website's web-link. Update your email with RTA/DP for direct future communications.
Valiant Labs approved director re-appointments/continuations, ensuring leadership. It's shifting its registered office and opening a new corporate office. The company will invest up to ₹60 Cr in its wholly-owned subsidiary, VASPL (FY26 turnover ₹41.65 Cr), to bolster its capital and working capital needs.
Valiant Laboratories' board has approved exploring strategic restructuring options across its group. This initiative aims to unlock shareholder value, simplify the structure, and achieve operational synergies for focused future growth.
Valiant Labs' wholly owned subsidiary began commercial ops at its new Gujarat greenfield plant. This move strengthens backward integration, diversifies into specialty chemicals, and boosts Acetic Anhydride production, partly funded by IPO proceeds.